Clinical Trial Update: Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjunctive minocycline with standard care for autoimmune encephalitis has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Xijing Hospital | Conditions: Autoimmune Encephalitis | Phase 2 | Status: COMPLETED